Novel Anti-fibrotic Therapies
Fibrosis is a major player in cardiovascular disease, both as a contributor to the development of disease, as well as a post-injury response that drives progression. Despite the identification of many mechanisms responsible for cardiovascular fibrosis, to date no treatments have emerged that have ef...
Saved in:
Main Authors: | Benita L. McVicker (Author), Robert G. Bennett (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dually Active Polycation/miRNA Nanoparticles for the Treatment of Fibrosis in Alcohol-Associated Liver Disease
by: Chuhan Zhang, et al.
Published: (2022) -
Pre-eclampsia during pregnancy and risk of endometrial cancer: a systematic review and meta-analysis
by: H Jordao, et al.
Published: (2023) -
Stress, coping, and psychological resilience among physicians
by: Emily O'Dowd, et al.
Published: (2018) -
Anti-fibrotic Potential of AT2 Receptor Agonists
by: Yan Wang, et al.
Published: (2017) -
Investigating Student Engagement and Making Science Real during a Pandemic: Bioskills at Home, a Case Study
by: Sarah Rayment, et al.
Published: (2022)